Possible fluconazole-fentanyl interaction-a case report.

Suppr

超能文献

作者信息

Hallberg Pär, Martén Leif, Wadelius Mia

出版信息

Eur J Clin Pharmacol. 2006 Jun;62(6):491-2. doi: 10.1007/s00228-006-0120-4. Epub 2006 Apr 21.

DOI:10.1007/s00228-006-0120-4

PMID:16758267

Abstract

摘要

相似文献

Possible fluconazole-fentanyl interaction-a case report.

Eur J Clin Pharmacol. 2006 Jun;62(6):491-2. doi: 10.1007/s00228-006-0120-4. Epub 2006 Apr 21.

Respiratory depression related to multiple drug-drug interactions precipitated by a fluconazole loading dose in a patient treated with oxycodone.

Eur J Clin Pharmacol. 2017 Jun;73(6):787-788. doi: 10.1007/s00228-017-2215-5. Epub 2017 Mar 9.

Withdrawal symptoms from transdermal fentanyl (TDF) after an allogeneic peripheral blood stem cell transplant (PBSCT).

Pain Med. 2006 Mar-Apr;7(2):164-5. doi: 10.1111/j.1526-4637.2006.00107.x.

Fluconazole-induced convulsions at serum trough concentrations of approximately 80 microg/mL.

Ther Drug Monit. 2000 Oct;22(5):635-6. doi: 10.1097/00007691-200010000-00022.

Rhabdomyolysis in a patient receiving atorvastatin and fluconazole.

Eur J Clin Pharmacol. 2005 Feb;60(12):905-7. doi: 10.1007/s00228-004-0858-5. Epub 2004 Dec 30.

Transdermal fentanyl (Duragesic): respiratory arrest in adolescents.

CMAJ. 2004 Oct 12;171(8):991-2.

Effect of voriconazole and fluconazole on the pharmacokinetics of intravenous fentanyl.

Eur J Clin Pharmacol. 2008 Jan;64(1):25-30. doi: 10.1007/s00228-007-0398-x. Epub 2007 Nov 7.

The CYP 3A4 inhibitor itraconazole has no effect on the pharmacokinetics of i.v. fentanyl.

Br J Anaesth. 1998 Oct;81(4):598-600. doi: 10.1093/bja/81.4.598.

Case report: delirium due to a diltiazem-fentanyl CYP3A4 drug interaction.

Gen Hosp Psychiatry. 2010 Nov-Dec;32(6):648.e9-648.e10. doi: 10.1016/j.genhosppsych.2010.08.003. Epub 2010 Sep 22.

Opioid-induced respiratory depression resulting from transdermal fentanyl-clarithromycin drug interaction in a patient with advanced COPD.

J Pain Symptom Manage. 2009 Jun;37(6):e2-5. doi: 10.1016/j.jpainsymman.2009.02.230.

引用本文的文献

Audio-Visual Hallucinations in a Patient Poststem Cell Transplant.

Indian J Palliat Care. 2019 Oct-Dec;25(4):592-593. doi: 10.4103/IJPC.IJPC_43_19.

Influence of aprepitant and localization of the patch on fentanyl exposure in patients with cancer using transdermal fentanyl.

Oncotarget. 2018 Apr 6;9(26):18269-18276. doi: 10.18632/oncotarget.24812.

A review of factors explaining variability in fentanyl pharmacokinetics; focus on implications for cancer patients.

Br J Clin Pharmacol. 2017 Feb;83(2):294-313. doi: 10.1111/bcp.13129. Epub 2016 Oct 29.

[Interaction of opioid analgesics at the level of biotransformation].

Schmerz. 2016 Dec;30(6):519-525. doi: 10.1007/s00482-016-0141-6.

Clinically significant drug-drug interactions involving opioid analgesics used for pain treatment in patients with cancer: a systematic review.

Drug Des Devel Ther. 2015 Sep 16;9:5255-67. doi: 10.2147/DDDT.S86983. eCollection 2015.

Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugs.

Br J Cancer. 2013 Mar 19;108(5):1071-8. doi: 10.1038/bjc.2013.48. Epub 2013 Feb 14.

Effect of voriconazole and fluconazole on the pharmacokinetics of intravenous fentanyl.

Eur J Clin Pharmacol. 2008 Jan;64(1):25-30. doi: 10.1007/s00228-007-0398-x. Epub 2007 Nov 7.

本文引用的文献

Fentanyl use, misuse, and abuse: a summary of 23 postmortem cases.

J Anal Toxicol. 2003 Oct;27(7):499-504. doi: 10.1093/jat/27.7.499.

Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain.

Drug Saf. 2003;26(13):951-73. doi: 10.2165/00002018-200326130-00004.

Itraconazole-fentanyl interaction in a cancer patient.

J Pain Symptom Manage. 2002 Sep;24(3):284-6. doi: 10.1016/s0885-3924(02)00477-3.

Duragesic transdermal patch: postmortem tissue distribution of fentanyl in 25 cases.

J Anal Toxicol. 2000 Oct;24(7):627-34. doi: 10.1093/jat/24.7.627.

Drug interactions of the newer oral antifungal agents.

Br J Dermatol. 1999 Nov;141 Suppl 56:26-32. doi: 10.1046/j.1365-2133.1999.00011.x.

Ritonavir's role in reducing fentanyl clearance and prolonging its half-life.

Anesthesiology. 1999 Sep;91(3):681-5. doi: 10.1097/00000542-199909000-00020.

The CYP 3A4 inhibitor itraconazole has no effect on the pharmacokinetics of i.v. fentanyl.

Br J Anaesth. 1998 Oct;81(4):598-600. doi: 10.1093/bja/81.4.598.

The effect of intravenous and oral fluconazole on the pharmacokinetics and pharmacodynamics of intravenous alfentanil.

Anesth Analg. 1998 Jul;87(1):190-4. doi: 10.1097/00000539-199807000-00039.

Long-term treatment of cancer pain with transdermal fentanyl.

J Pain Symptom Manage. 1998 Mar;15(3):168-75. doi: 10.1016/s0885-3924(97)00361-8.

Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes. Role of CYP3A4.

Drug Metab Dispos. 1996 Sep;24(9):932-9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验